Apheresis Market worth .7 billion by 2025

Posted by MV Mukund on March 20th, 2024

Overview of This Study:

This research employed a large number of primary and secondary sources. In order to determine the segmentation kinds, industry trends, major players, competitive landscape, important market dynamics, and major player strategies, the research procedure entailed analyzing a variety of industry-affecting aspects.

Major Growth Driving Factors:

The growing number of injury cases and the rising prevalence of chronic diseases, the growing demand from biopharmaceutical companies for source plasma, the growing demand for blood components and growing concerns about blood safety, the rise in complex surgical procedures, and the favorable reimbursement for apheresis procedures are the main factors driving the market for apheresis.

However, a number of factors are anticipated to restrict market growth in the upcoming years, including the high cost of therapeutic apheresis procedures and devices, the rental model for apheresis device installation, the low number of blood donations using apheresis due to lack of awareness, and the strict donor recruitment criteria.

Revenue Growth Forecast:

The global apheresis market boasts a total value of .7 billion in 2019 and is projected to register a growth rate of 8.1% to reach a value of .7 billion by 2025.

Download PDF Brochure@

Global Market Segmentation:

Throughout the projection period, the centrifugation technology segment is anticipated to develop at the greatest CAGR.

The apheresis market is divided into membrane separation technology and centrifugation technology segments based on technology. Over the course of the projection period, the centrifugation segment is anticipated to increase at the greatest CAGR. The advantages of centrifugation over membrane separation, namely its great efficiency and capacity to separate all forms of blood components, can be credited for this rapid expansion.

Over the course of the forecast period, the photopheresis segment is anticipated to increase at the greatest CAGR.

The apheresis market is divided into segments based on application, including photopheresis, erythrocytapheresis, leukapheresis, plateletpheresis, and plasmapheresis. Over the course of the projected period, the photopheresis is anticipated to increase at the fastest rate. The increased incidence of blood diseases and the growing need for photopheresis in the treatment of organ transplant rejection are responsible for this segment's rapid rise.

End User:

Throughout the projection period, the hospitals and transfusion centers sector is anticipated to grow at the fastest rate.

The apheresis market has been divided into hospitals and transfusion facilities, blood collection facilities and blood component suppliers, and other end users based on end user. The segment with the highest predicted compound annual growth rate (CAGR) during the projected period is hospitals and transfusion centers. This segment's rapid expansion can be ascribed to the expanding indications of therapeutic apheresis, increased awareness of apheresis as a therapy, and the growing use of apheresis in the treatment of numerous diseases.

Revenue Growth Forecast:

In 2018, North America held the biggest market share.

In 2018, North America held the greatest share of the market for apheresis, followed by Europe. The region's substantial share can be ascribed to its easier access to cutting-edge blood collection technologies, its well-established healthcare infrastructure, and the growing number of top apheresis businesses operating in the nation.

Request Sample Pages@

Global Key Players:

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441

Like it? Share it!

MV Mukund

About the Author

MV Mukund
Joined: March 18th, 2020
Articles Posted: 77

More by this author